Nifedipine versus tamsulosin for the management of lower ureteral stones

Università degli Studi di Torino, Torino, Piedmont, Italy
The Journal of Urology (Impact Factor: 3.75). 09/2004; 172(2):568-71. DOI: 10.1097/01.ju.0000132390.61756.ff
Source: PubMed

ABSTRACT We evaluate and compare the effectiveness of 2 different medical therapies during watchful waiting in patients with lower ureteral stones.
A total of 86 patients with stones less than 1 cm located in the lower ureter (juxtavesical or intramural tract) were enrolled in the study and were randomly divided into 3 groups. Group 1 (30) and 2 (28) patients received daily oral treatment of 30 mg deflazacort, (maximum 10 days). In addition group 1 patients received 30 mg nifedipine slow-release (maximum 28 days) and group 2 received 1 daily oral therapy of 0.4 mg tamsulosin (maximum 28 days), Group 3 patients (28) were used as controls. Statistical analyses were performed using Student's test, ANOVA test, chi-square test and Fisher's exact test.
The average stone size for groups 1 to 3 was 4.7, 5.42 and 5.35 mm, respectively, which was not statistically significant. Expulsion was observed in 24 of 30 patients in group 1 (80%), 24 of 28 in group 2 (85%) and 12 of 28 in group 3 (43%). The difference in groups 1 and 2 with respect to group 3 was significant. Average expulsion time for groups 1 to 3 was 9.3, 7.7 and 12 days, respectively. A statistically significant difference was noted between groups 2 and 3. Mean sodium diclofenac dosage per patient in groups 1 to 3 was 19.5, 26, and 105 mg, respectively. A statistical significant difference was observed between groups 1 and 2 with respect to group 3.
Medical treatments with nifedipine and tamsulosin proved to be safe and effective as demonstrated by the increased stone expulsion rate and reduced need for analgesic therapy. Moreover medical therapy, particularly in regard to tamsulosin, reduced expulsion time.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Urolithiasis is a worldwide disease which has affected humans from ancient eras to modern times. Recently, societal changes have altered the epidemiology of urinary calculi. The incidence of urolithiasis is higher in industrialized countries. Obese people are known to have a higher risk of stone formation. Metabolic syndrome has resulted in an increasing rate of nephrolithiasis among women. There are many useful tools for diagnosing urolithiasis, including conventional plain radiography, intravenous urography, ultrasonography, computed tomography (CT), and nuclear medicine. Nonenhanced CT has high sensitivities and specificities. It can be rapidly performed without intravenous administration of contrast material and can therefore be used in patients with severely impaired renal function. Beyond that, it can reveal extraurinary causes of flank pain. However, concerns about radiation exposure and costs remain. Since ancient times, hundreds of natural plant extracts and more recently, synthetic chemicals have been proposed to eliminate urinary calculi. Clinical trials demonstrated that calcium channel blockers and adrenergic antagonists are effective in enhancing stone passage. Shock wave lithotripsy (SWL) can successfully treat renal calculi. A meta-analysis study revealed that SWL is more effective in treating urinary calculi with a lower-frequency mode. Highly dense stones are more refractory to SWL. The stone composition can be evaluated by preoperative CT attenuation values. Patients with preoperative Houndsfield units (HUs) of >750 have a 10.5-times greater chance of needing three or more sessions of SWL treatment compared to patients whose HUs are <750. Ureteroscopy is a safe treatment for managing ureter stones when performed by experienced hands and ureteroscopy is preferred over SWL in patients with a larger upper-ureter stone, those who are pregnancy, and those with bleeding diathesis.
    Urological Science 03/2012; 23(1):5-8. DOI:10.1016/j.urols.2011.12.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to evaluate whether tamsulosin, an alpha--blocker, has an effect on decreasing spontaneous ureteral contractility with or without phenylephrine, an alpha--agonist. Additionally, nifedipine, terpene mixure (Rowatinex®) were tested and compared with each other. We obtained ureteral segments from freshly killed eight--week--old rabbits. Preparation was performed in aerated Krebs buffer (95% oxygen and 5% carbon dioxide) at a constant temperature of 37℃. All segments were suspended into organ tissue baths containing aerated Krebs buffer using stainless steel hangers and clips. The ureter divided into four segments; upper, middle, low and uretero--vesical junction. Each ureteral segment was suspended longitudinally and circularly by opposite corners, respectively. Tamsulosin, nifedipine, and terpene mixture were separately applied into the segments. Contractile activities of each drug was recorded and analyzed by PowerLab data acquistition system (AD instruments CO., USA). Area under the curve was compared between before and after each drug application for each 5 minutes with or without pheylephrine. Statistical analysis was performed using the unpaired Student's t test. Under Krebs solution, ureteral smooth muscle Contractility was significantly decreased in all segments over 10--6M in tamsulosin, 10--7M in nifedipine and 0.001x1 concentrations in terpene mixture (p=0.038). However, under Krebs solution with 10--5 M phenylephrine, there was no significant difference at all concentrations in tamsoluin and nifedipine. In contrast to tamsolusin and nifedipine, there was a significant decrease in ureteral smooth muscle Contractility in most of segments at 0.01x1 concentrations (p=0.042) in terpene mixture. Tamsulosin, nifedipine, and terpene mixture showed the effect on spontaneous ureteral contractility. In particular, terpene mixture might have the better effect on decreasing ureteral smooth muscle contractility.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hintergrund Die Steinerkrankung ist wegen ihrer steigenden Prävalenz und Inzidenz mittlerweile als Volkskrankheit zu werten. Das Ziel der Therapie ist die Steinfreiheit, die u. a. durch die Steinlokalisation, die Steinzusammensetzung und die Steingröße beeinflusst wird. Fragestellung Beleuchtung der zur Verfügung stehenden konservativen und operativen Therapiemöglichkeiten. Ergebnisse Neben der extrakorporalen Stoßwellenlithotripsie, der Ureterorenoskopie und der perkutanen Nephrolitholapaxie als operativen Verfahren stehen das Begleiten des Spontanabgangs mit oder ohne expulsive Therapie, das beobachtende Abwarten und die Chemolitholyse als konservative Therapiestrategien zur Verfügung. Das Einordnen des Steinpatienten in eine Risikogruppe mit spezifischer Diagnostik und Metaphylaxe soll das Rezidivrisiko senken. Schlussfolgerung Die Entscheidung für eine richtige Therapie ist abhängig von der Patientensituation und muss individuell getroffen werden.
    Der Nephrologe 05/2014; 9(3):213-221. DOI:10.1007/s11560-013-0849-6

Full-text (2 Sources)

Available from
May 21, 2014